GN Store Nord A/S (OTCMKTS:GGNDF – Get Free Report) and ENDRA Life Sciences (NASDAQ:NDRA – Get Free Report) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, earnings, valuation, profitability, dividends and institutional ownership.
Analyst Recommendations
This is a breakdown of recent recommendations for GN Store Nord A/S and ENDRA Life Sciences, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| GN Store Nord A/S | 0 | 0 | 0 | 0 | 0.00 |
| ENDRA Life Sciences | 1 | 0 | 1 | 0 | 2.00 |
ENDRA Life Sciences has a consensus price target of $25.00, suggesting a potential upside of 439.37%. Given ENDRA Life Sciences’ stronger consensus rating and higher possible upside, analysts clearly believe ENDRA Life Sciences is more favorable than GN Store Nord A/S.
Profitability
| Net Margins | Return on Equity | Return on Assets | |
| GN Store Nord A/S | N/A | N/A | N/A |
| ENDRA Life Sciences | N/A | -246.34% | -150.81% |
Earnings & Valuation
This table compares GN Store Nord A/S and ENDRA Life Sciences”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| GN Store Nord A/S | N/A | N/A | N/A | $4.35 | 3.52 |
| ENDRA Life Sciences | N/A | N/A | -$7.03 million | ($6.38) | -0.73 |
ENDRA Life Sciences is trading at a lower price-to-earnings ratio than GN Store Nord A/S, indicating that it is currently the more affordable of the two stocks.
Institutional and Insider Ownership
35.3% of GN Store Nord A/S shares are owned by institutional investors. Comparatively, 1.2% of ENDRA Life Sciences shares are owned by institutional investors. 10.0% of ENDRA Life Sciences shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Summary
GN Store Nord A/S beats ENDRA Life Sciences on 5 of the 9 factors compared between the two stocks.
About GN Store Nord A/S
GN Store Nord A/S provides hearing, audio, video, and gaming solutions in Denmark, rest of Europe, North America, and internationally. The company operates through GN Hearing and GN Audio segments. The GN Hearing segment produces and sells hearing instruments and products. The GN Audio segment supplies headsets, video cameras, and speakerphones for professional use and consumer products. It offers its products under the ReSound, Jabra, Beltone, Interton, Danavox, BlueParrott, FalCom, and SteelSeries brands. GN Store Nord A/S was founded in 1869 and is based in Ballerup, Denmark.
About ENDRA Life Sciences
ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.
Receive News & Ratings for GN Store Nord A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GN Store Nord A/S and related companies with MarketBeat.com's FREE daily email newsletter.
